PER
Click for more information
3.57% 8.1¢ percheron therapeutics limited

witnessing the start of a 5 to Disallowed., page-273

  1. wormy
    2,405 Posts.
    clock Created with Sketch.
    16/11/11
    06:44
    Post #: 9291727
    Hi,

    your Q =?....I question why, when alt103 has an early end point and the trials were completed approx 3 weeks ago that we would not expect the results of research study any day now.

    A = ? ..maybe a follow on time period is set for patients after trial = side effects .ect ect = maybe a Q for Ace to expand on.



    (.>_<)
    ANP Price at posting: 16.0¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

GWR Scoping study and Phase 2 drilling progress Prospect Ridge magnesium play for GWR
right-arrow Created with Sketch.
HMD HeraMED delivers digital maternity care to select clinics with Telstra
right-arrow Created with Sketch.
JGH Jade's strong gas exploration results another step towards Mongolian development
right-arrow Created with Sketch.
CTT Cettire has launched in China – but can it turn its share price around?
right-arrow Created with Sketch.
MYR Myer lobs proposed merger at major shareholder Premier Investments
right-arrow Created with Sketch.
IMU Imugene doses first cancer patient in Oasis trial
right-arrow Created with Sketch.
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.1¢ 		Change
-0.003(3.57%) 		Mkt cap ! $75.73M
Open High Low Value Volume
8.2¢ 8.2¢ 8.1¢ $8.391K 102.4K

Buyers (Bids)

No. Vol. Price($)
3 151557 8.1¢
 

Sellers (Offers)

Price($) Vol. No.
8.2¢ 169 1
View Market Depth
Last trade - 11.44am 26/06/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.